ORIGINAL PAPER
KLF14 restrained NLRP3-mediated pyroptosis in sepsis-induced acute lung injury by activating DTX3L
1
Department of Critical Care Medicine, Kunming Third People’s Hospital (Yunnan Province Clinical Center for Infectious Diseases), Kunming 650000, Yunnan Province, China
2
Department of Drug-Resistant and Critical Tuberculosis, Kunming Third People’s Hospital (Yunnan Province Clinical Medical Center for Infectious Diseases), Kunming 650000, Yunnan Province, China
3
General Internal Medicine Department, Kunming Third People’s Hospital (Yunnan Province Clinical Medical Center for Infectious Diseases), Kunming 650000, Yunnan Province, China
These authors had equal contribution to this work
Submission date: 2024-12-24
Final revision date: 2025-05-26
Acceptance date: 2025-06-21
Online publication date: 2026-01-09
Corresponding author
Zhongxu Ma
Kunming Third People’s Hospital (Yunnan Province Clinical Center for Infectious Diseases)
Kunming Third People’s Hospital (Yunnan Province Clinical Center for Infectious Diseases)
KEYWORDS
ABSTRACT
Introduction:
Acute lung injury (ALI) is characterized by inflammation of the lungs, leading to impaired gas exchange and respiratory distress. This study aimed to investigate the mechanisms underlying the role of Krüppel-like factor 14 (KLF14) in ALI pathogenesis.
Material and Methods:
Protein and gene expression levels were quantified using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot. Cell viability and pyroptosis were assessed by Cell Counting Kit-8 (CCK-8) and flow cytometry. Interleukin (IL)-18 and IL-1 levels were measured by enzyme-linked immunosorbent assay (ELISA), while lactate dehydrogenase (LDH) activity was evaluated with a commercial assay kit. The interaction between Deltex E3 ubiquitin ligase 3-like (DTX3L) and KLF14 or nucleotide-binding domain like receptor 3 (NLRP3) was analyzed using chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Co-IP), and dual-luciferase reporter assay.
Results:
BEAS-2B cells treated with lipopolysaccharide (LPS) exhibited reduced viability and elevated pyroptosis-related markers. Notably, KLF14 upregulation suppressed NLRP3-mediated pyroptosis in LPS-induced cells. Similarly, DTX3L overexpression attenuated pyroptosis in LPS-treated BEAS-2B cells. Mechanistically, KLF14 enhanced DTX3L transcription, and DTX3L promoted NLRP3 degradation via ubiquitination. Furthermore, KLF14 upregulation inhibited NLRP3-driven pyroptosis by inducing DTX3L expression.
Conclusions:
Upregulation of KLF14 inhibited NLRP3-mediated pyroptosis through DTX3L activation, thereby improving sepsis-induced acute lung injury.
Acute lung injury (ALI) is characterized by inflammation of the lungs, leading to impaired gas exchange and respiratory distress. This study aimed to investigate the mechanisms underlying the role of Krüppel-like factor 14 (KLF14) in ALI pathogenesis.
Material and Methods:
Protein and gene expression levels were quantified using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot. Cell viability and pyroptosis were assessed by Cell Counting Kit-8 (CCK-8) and flow cytometry. Interleukin (IL)-18 and IL-1 levels were measured by enzyme-linked immunosorbent assay (ELISA), while lactate dehydrogenase (LDH) activity was evaluated with a commercial assay kit. The interaction between Deltex E3 ubiquitin ligase 3-like (DTX3L) and KLF14 or nucleotide-binding domain like receptor 3 (NLRP3) was analyzed using chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Co-IP), and dual-luciferase reporter assay.
Results:
BEAS-2B cells treated with lipopolysaccharide (LPS) exhibited reduced viability and elevated pyroptosis-related markers. Notably, KLF14 upregulation suppressed NLRP3-mediated pyroptosis in LPS-induced cells. Similarly, DTX3L overexpression attenuated pyroptosis in LPS-treated BEAS-2B cells. Mechanistically, KLF14 enhanced DTX3L transcription, and DTX3L promoted NLRP3 degradation via ubiquitination. Furthermore, KLF14 upregulation inhibited NLRP3-driven pyroptosis by inducing DTX3L expression.
Conclusions:
Upregulation of KLF14 inhibited NLRP3-mediated pyroptosis through DTX3L activation, thereby improving sepsis-induced acute lung injury.
REFERENCES (38)
1.
Qiao X, Yin J, Zheng Z, et al. (2024): Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications. Cell Commun Signal 22: 241.
2.
Li W, Li D, Chen Y, et al. (2022): Classic signaling pathways in alveolar injury and repair involved in sepsis-induced ALI/ARDS: New research progress and prospect. Dis Markers 2022: 6362344.
3.
Hu Q, Zhang S, Yang Y, et al. (2022): Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Mil Med Res 9: 61.
4.
Wei T, Zhang C, Song Y (2022): Molecular mechanisms and roles of pyroptosis in acute lung injury. Chin Med J (Engl) 135: 2417-2426.
5.
Wu J, Lan Y, Wu J, et al. (2023): Sepsis-induced acute lung injury is alleviated by small molecules from dietary plants via pyroptosis modulation. J Agric Food Chem 71: 12153-12166.
6.
Zhou S, Yang X, Mo K, et al. (2024): Pyroptosis and polarization of macrophages in septic acute lung injury induced by lipopolysaccharide in mice. Immun Inflamm Dis 12: e1197.
7.
Cai D, Zhao Y, Yu F (2022): Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis. Cell Death Discov 8: 368.
8.
Li ZF, Wang YC, Feng QR, et al. (2022): Inhibition of the C3a receptor attenuates sepsis-induced acute lung injury by suppressing pyroptosis of the pulmonary vascular endothelial cells. Free Radic Biol Med 184: 208-217.
9.
Zeng Y, Qin Q, Li K, et al. (2019): PKR suppress NLRP3-pyroptosis pathway in lipopolysaccharide-induced acute lung injury model of mice. Biochem Biophys Res Commun 519: 8-14.
10.
Vela-Rodríguez C, Lehtiö L (2022): Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer. Biochem Soc Trans 50: 1683-1692.
11.
Chen L, Niu W, Zang H, et al. (2024): DTX3L accelerates pancreatic cancer progression via FAK/PI3K/AKT axis. Biochem Genet 62: 814-830.
12.
Zhang Y, Mao D, Roswit WT, et al. (2015): PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat Immunol 16: 1215-1227.
13.
Lin S (2023): DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer. Biochem Biophys Res Commun 681: 106-110.
14.
Zhou Z, Shang L, Zhang Q, et al. (2023): DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury. Biochim Biophys Acta Mol Cell Res 1870: 119433.
15.
Sweet DR, Fan L, Hsieh PN, et al. (2018): Krüppel-like factors in vascular inflammation: Mechanistic insights and therapeutic potential. Front Cardiovasc Med 5: 6.
16.
Qin J, Zhou L, Yu L, et al. (2024): Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression. Front Pharmacol 15: 1365928.
17.
Hu W, Lu H, Zhang J, et al. (2018): Krüppel-like factor 14, a coronary artery disease associated transcription factor, inhibits endothelial inflammation via NF-B signaling pathway. Atherosclerosis 278: 39-48.
18.
Liu L, Yuan Y, Zhou Y, et al. (2022): The transcription factor KLF14 attenuates LPS-induced acute lung injury by ameliorating apoptosis of alveolar epithelial cells in mice. Mol Immunol 152: 67-77.
19.
Cao X, Zhang C, Zhang X, et al. (2019): MiR-145 negatively regulates TGFBR2 signaling responsible for sepsis-induced acute lung injury. Biomed Pharmacother 111: 852-858.
20.
Kumar V (2020): Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol 11: 1722.
21.
Mokrá D (2020): Acute lung injury – from pathophysiology to treatment. Physiol Res 69 (Suppl 3): S353-S366.
22.
Wei X, Yang R, Wang C, et al. (2017): A novel role for the Krüppel-like factor 14 on macrophage inflammatory response and atherosclerosis development. Cardiovasc Pathol 27: 1-8.
23.
Liu B, Wang Z, He R, et al. (2022): Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway. Clin Sci (Lond) 136: 273-289.
24.
Fan XY, Ma ZX, Tang LB, et al. (2023): lncRNA NEAT1 mediates LPS-induced pyroptosis of BEAS-2B cells via targeting miR-26a-5p/ROCK1 axis. Kaohsiung J Med Sci 39: 665-674.
25.
Zeng Z, Fu Y, Li M, et al. (2024): Guben Qingfei decoction attenuates LPS-induced acute lung injury by modulating the TLR4/NF-B and Keap1/Nrf2 signaling pathways. J Ethnopharmacol 323: 117674.
26.
Lou W, Yan J, Wang W (2021): Downregulation of miR-497-5p improves sepsis-induced acute lung injury by targeting IL2RB. Biomed Res Int 2021: 6624702.
27.
Zhang G, Wang L (2022): Leonurine: A compound with the potential to prevent acute lung injury. Exp Ther Med 23: 358.
28.
Chen X, Shi W, Zhang H (2020): The role of KLF14 in multiple disease processes. Biofactors 46: 276-282.
29.
Yang Q, Civelek M (2020): Transcription factor KLF14 and metabolic syndrome. Front Cardiovasc Med 7: 91.
30.
Chen X, Tan Q, Wang Y, et al. (2019): Overexpression of KLF14 protects against immune-mediated hepatic injury in mice. Lab Invest 99: 37-47.
31.
Kawata M, Teramura T, Ordoukhanian P, et al. (2022): Krüppel-like factor-4 and Krüppel-like factor-2 are important regulators of joint tissue cells and protect against tissue destruction and inflammation in osteoarthritis. Ann Rheum Dis 81: 1179-1188.
32.
Liu Y, Zhang Y, Feng Q, et al. (2021): GPA peptide attenuates sepsis-induced acute lung injury in mice via inhibiting oxidative stress and pyroptosis of alveolar macrophage. Oxid Med Cell Longev 2021: 5589472.
33.
Du Z, Liu M, Wang Z, et al. (2021): EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPAR. Cell Prolif 54: e13072.
34.
Weng J, Wu J, Chen W, et al. (2020): KLF14 inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells by downregulating WNT3A. Am J Transl Res 12: 4445-4455.
35.
Huang J, Chen Z, Ye Y, et al. (2023): DTX3L enhances type i interferon antiviral response by promoting the ubiquitination and phosphorylation of TBK1. J Virol 97: e0068723.
36.
Huang P, Liu W, Chen J, et al. (2020): TRIM31 inhibits NLRP3 inflammasome and pyroptosis of retinal pigment epithelial cells through ubiquitination of NLRP3. Cell Biol Int 44: 2213-2219.
37.
Li D, Ren W, Jiang Z, et al. (2018): Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury. Mol Med Rep 18: 4399-4409.
38.
Zhang Y, Zhang H, Li S, et al. (2022): Metformin alleviates LPS-induced acute lung injury by regulating the SIRT1/NF-B/NLRP3 pathway and inhibiting endothelial cell pyroptosis. Front Pharmacol 13: 801337.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
